TY  - GEN
AU  - Lok,Benjamin H
AU  - Gardner,Eric E
AU  - Schneeberger,Valentina E
AU  - Ni,Andy
AU  - Desmeules,Patrice
AU  - Rekhtman,Natasha
AU  - de Stanchina,Elisa
AU  - Teicher,Beverly A
AU  - Riaz,Nadeem
AU  - Powell,Simon N
AU  - Poirier,John T
AU  - Rudin,Charles M
TI  - PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
SN  - 1557-3265
PY  - 2018///0206
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Cell Line, Tumor
KW  - Cisplatin
KW  - Dacarbazine
KW  - Drug Synergism
KW  - Etoposide
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Genomics
KW  - methods
KW  - Humans
KW  - Indoles
KW  - Mice
KW  - Nuclear Proteins
KW  - genetics
KW  - Phthalazines
KW  - Piperazines
KW  - Poly (ADP-Ribose) Polymerase-1
KW  - antagonists & inhibitors
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Small Cell Lung Carcinoma
KW  - drug therapy
KW  - Temozolomide
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-1040
ER  -